The global microcarriers market size is expected to reach USD 4.11 billion by 2032, according to a new study by Polaris Market Research. The report “Microcarriers Market Share, Size, Trends, Industry Analysis Report, By Product (Consumables, Equipment); By Application; By Therapy; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Microcarriers are gaining traction nowadays, with increased research activities exploring potential benefits in the healthcare sector. The ability to adjust its therapeutic properties according to diverse needs is one of the major factors driving its use as an alternative to regenerative medicine and drug delivery. They can carry drugs, peptides, and other therapeutic compounds, which is grabbing attention in the pharmaceutical space. They are widely employed in regenerative research activities as they are prominent in cell manufacturing and drug carrier tasks.
Healthcare researchers are increasing their focus on cell therapy with a view to creating treatments for existing health issues, such as cancer, urinary problems, autoimmune diseases, repairing damaged cartilage in joints, and more. This will necessitate the need for microcarriers due to their potential to carry extracellular matrix proteins and peptides. In cell manufacturing, microcarriers are used to culture large amounts of cells in small volumes, enhancing surface attachment.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/microcarriers-market/request-for-sample
The growing development of microcarriers with advanced capabilities is boosting the growth of the microcarrier industry. For instance, in November 2023, Teijin Frontier introduced non-oven microcarriers for cell culture. They enable speedy, large-scale, high-quality cell culture.
The rising research innovations, along with the new product launches in the marketplace, are expected to boost the applications of microcarriers. For instance, in October 2023, Kuraray Co. announced the development of PVA hydrogel microcarriers in regenerative medicine for cell cultures, which is likely to launch in 2024.
Companies are working to drive advancements in bio-sustainability with cell-cultured meat production and expand their research centers to meet their objectives. Notably, in 2023, Cytoniche Biotechnology unveiled its new Centre of Excellence, a research and development center in China. In the same year, Matrix F.T. introduced an initially cultivated chicken made up of its edible microcarriers.
Microcarriers Market Report Highlights
Polaris Market Research has segmented the microcarriers market report based on product, application, therapy, and region:
Microcarriers, Product Outlook (Revenue - USD Billion, 2019 - 2032)
Microcarriers, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Microcarriers, Therapy Outlook (Revenue - USD Billion, 2019 - 2032)
Microcarriers, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
Report Attributes |
Details |
Market Size Value in 2024 |
USD 1.74 billion |
Revenue Forecast in 2032 |
USD 4.11 billion |
CAGR |
11.4% from 2024 – 2032 |
Base Year |
2023 |
Historical Data |
2019 – 2022 |
Forecast Period |
2024 – 2032 |
Quantitative Units |
Revenue in USD billion and CAGR from 2024 to 2032 |
Segments Covered |
By Product, By Application, By Therapy, By Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Customization |
Report customization as per your requirements with respect to countries, regions, and segmentation. |
For Specific Research Requirements |